Success Metrics

Clinical Success Rate
87.0%

Based on 20 completed trials

Completion Rate
87%(20/23)
Active Trials
6(15%)
Results Posted
20%(4 trials)
Terminated
3(7%)

Phase Distribution

Ph not_applicable
13
32%
Ph phase_2
7
17%
Ph phase_4
11
27%
Ph phase_3
3
7%
Ph phase_1
6
15%
Ph early_phase_1
1
2%

Phase Distribution

7

Early Stage

7

Mid Stage

14

Late Stage

Phase Distribution41 total trials
Early Phase 1First-in-human
1(2.4%)
Phase 1Safety & dosage
6(14.6%)
Phase 2Efficacy & side effects
7(17.1%)
Phase 3Large-scale testing
3(7.3%)
Phase 4Post-market surveillance
11(26.8%)
N/ANon-phased studies
13(31.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.0%

20 of 23 finished

Non-Completion Rate

13.0%

3 ended early

Currently Active

6

trials recruiting

Total Trials

41

all time

Status Distribution
Active(7)
Completed(20)
Terminated(3)
Other(11)

Detailed Status

Completed20
unknown11
Recruiting4
Terminated3
Active, not recruiting2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
41
Active
6
Success Rate
87.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.4%)
Phase 16 (14.6%)
Phase 27 (17.1%)
Phase 33 (7.3%)
Phase 411 (26.8%)
N/A13 (31.7%)

Trials by Status

completed2049%
recruiting410%
not_yet_recruiting12%
unknown1127%
active_not_recruiting25%
terminated37%

Recent Activity

Clinical Trials (41)

Showing 20 of 41 trialsScroll for more
NCT07076641Phase 3

Efficacy and Safety of Intravenous Lidocaine Versus Placebo in Patients Receiving Morphine-rachi Analgesia

Not Yet Recruiting
NCT04828083Phase 4

Systemic Lidocaine Versus Ultrasound-guided Adductor Canal Block for Patients Undergoing Total Knee Arthroplasty

Completed
NCT05788393Phase 4

Opioid Sparing Analgesia Continuous Intraoperative Infusion of Dexmedetomidine Versus Lidocaine for Laparoscopic Cholecystectomy

Completed
NCT06272461Not Applicable

Comparison of Intravenous Lidocaine vs Ketamine in Colorectal Surgery

Recruiting
NCT06703437Phase 1

Long Acting Neuraxial Peri-prostatic Block in Cancer

Active Not Recruiting
NCT06423456Not Applicable

Postoperative Pain Control Following Hysteroscopy

Completed
NCT05010148Phase 3

A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain

Recruiting
NCT05700214Not Applicable

Lidocaine Versus ESP - After Bariatric Surgery

Completed
NCT05742438Not Applicable

Effects of Dexmedetomidine/Lidocaine/Intrathecal Morphine on Cancer Metastasis Biomarker After Colorectal Surgery

Completed
NCT04316013Phase 3

Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial

Terminated
NCT05501600Phase 1

Neural Correlates of Lidocaine Analgesia

Completed
NCT04584749Phase 4

Lidocaine as an Anesthetic Adjuvant in Liver and Gastric Laparoscopic Surgery

Completed
NCT06557473Phase 4

Lidocaine Versus Fentanyl for Hemodynamic Stability

Completed
NCT05470166Not Applicable

Lidocaine Infusion With ERAS Protocol for Pancreatic Cancer Surgery: Effect on Pain and Patient Immunity.

Completed
NCT06516861Phase 1

Magnesium Sulphate and Lidocaine in Hemodynamic Changes and Cortisol Levels

Completed
NCT05231941Not Applicable

Comparison of Intraoperative Intravenous Lidocaine Infusion and Transversus Abdominis Plane (TAP) Block for Post-operative Analgesia Following Laproscopic Cholecystectomy

Completed
NCT06457100Phase 1

Esmolol Versus Lidocaine on the Quality of Postoperative Recovery in Patients Undergoing Functional Endoscopic Sinus Surgery

Active Not Recruiting
NCT06433713Phase 2

Effect of Intraoperative Intravenous Lidocaine on Postoperative Pain and Return of Bowel Function After Cesarean Sections

Completed
NCT06431165Phase 1

Effects of Different Doses of Intravenous Lidocaine Infusion on Peri-operative Pain and Incidence of Postoperative Chronic Pain Within ERAS Protocols, a Dose Finding Study.

Recruiting
NCT06090955Not Applicable

Modulating Surgery-Induced Blood-Brain Barrier Disruption in Elderly

Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
41